Clinical Trial Update: Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

This entry provides an update on a Phase 2 clinical trial comparing induction chemotherapy regimens GP (gemcitabine + cisplatin) and TPF (docetaxel + cisplatin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Cancer Hospital of Guangxi Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN